Gonadotropin-releasing hormone agonists and the skeleton

This publication has 36 references indexed in Scilit:

• Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study
  Fertility and Sterility, 1990
• THE EFFECTS OF NAFARELIN AND DANAZOL ON VERTEBRAL TRABECULAR BONE MASS IN PATIENTS WITH ENDOMETRIOSIS
  Clinical Endocrinology, 1990
• Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol
  Fertility and Sterility, 1989
• The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone Metabolism
  Journal of Clinical Endocrinology & Metabolism, 1988
• REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN
  Clinical Endocrinology, 1988
• Rapid reduction of uterine leiomyomas with monthly injections of D-Trp⁶-GnRH
  Gynecological Endocrinology, 1988
• Increased Bone Turnover During Gonadotropin-Releasing Hormone Superagonist-Induced Ovulation Inhibition*
  Journal of Clinical Endocrinology & Metabolism, 1987
• Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.
  BMJ, 1987
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
  Fertility and Sterility, 1984
• “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.
  Journal of Clinical Endocrinology & Metabolism, 1982